Invesco Ltd. Atossa Therapeutics, Inc. Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 58,669 shares of ATOS stock, worth $53,388. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,669
Previous 60,344
2.78%
Holding current value
$53,388
Previous $56,000
30.36%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ATOS
# of Institutions
88Shares Held
27.8MCall Options Held
63.6KPut Options Held
53.2K-
Black Rock Inc. New York, NY9.2MShares$8.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.59MShares$5.99 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.85MShares$2.59 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.86MShares$1.69 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.57 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $115M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...